Literature DB >> 10493500

Hypoxic cervical cancers with low apoptotic index are highly aggressive.

M Höckel1, K Schlenger, S Höckel, P Vaupel.   

Abstract

There is evidence from experimental work that hypoxia induces apoptosis in apoptosis-sensitive neoplastic cells and that this apoptotic sensitivity is lost during malignant progression. Oxygenation profiles and apoptotic indices in human squamous cell cancer of the uterine cervix have been determined, and a subgroup of tumors has been identified with low apoptotic index despite pronounced hypoxia representing carcinomas that consist of neoplastic cells with diminished apoptotic potential. These hypoxic low-apoptotic tumors show a high probability for lymphatic spread and for recurrence despite adjuvant treatment with radiation or chemotherapy in addition to radical surgery. The clinical results presented strongly support the hypothesis derived from experimental studies that the selection of apoptosis-insensitive neoplastic cell phenotypes in a hypoxic microenvironment is an important mechanism for malignant progression in solid tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493500

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  79 in total

1.  Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1.

Authors:  Isabel M Pires; Zuzana Bencokova; Chris McGurk; Ester M Hammond
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 2.  Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Authors:  Lara Milane; Shanthi Ganesh; Shruti Shah; Zhen-Feng Duan; Mansoor Amiji
Journal:  J Control Release       Date:  2011-04-08       Impact factor: 9.776

3.  Hypoxia inducible factor-1 alpha and multiple myeloma.

Authors:  Archana Bhaskar; Bhupendra Nath Tiwary
Journal:  Int J Adv Res (Indore)       Date:  2016-01-01

4.  Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience.

Authors:  Chan Kyo Kim; Sung Yoon Park; Byung Kwan Park; Won Park; Seung Jae Huh
Journal:  Eur Radiol       Date:  2014-04-25       Impact factor: 5.315

Review 5.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

Review 6.  MRI in medical practice and its future use in radiation oncology. Resume of XXV GOCO Congress (Montpellier) 2017.

Authors:  Xavier Druet; Estrella Acosta Sanchez; Ken Soleakhena; Anne Laprie; Jordi Sáez; Stéphanie Nougaret; Olivier Riou; Elodie Rigal; Laura Kibranian; Miguel Palacios; Ismael Membrive
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-05

Review 7.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines.

Authors:  Yun Jung Choi; Jin Kyung Rho; Sun Joo Lee; Won Seok Jang; Seung Sook Lee; Cheol Hyeon Kim; Jae Cheol Lee
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-15       Impact factor: 4.553

9.  In Vivo Therapeutic Silencing of Hypoxia-Inducible Factor 1 Alpha (HIF-1α) Using Single-Walled Carbon Nanotubes Noncovalently Coated with siRNA.

Authors:  Geoffrey Bartholomeusz; Paul Cherukuri; John Kingston; Laurent Cognet; Robert Lemos; Tonya K Leeuw; Laura Gumbiner-Russo; R Bruce Weisman; Garth Powis
Journal:  Nano Res       Date:  2009-04-17       Impact factor: 8.897

10.  Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.

Authors:  Laura M S Seeber; Ronald P Zweemer; René H M Verheijen; Paul J van Diest
Journal:  Obstet Gynecol Int       Date:  2010-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.